ArticleJournal of clinical medicine2026

KRAS Mutation Subtypes, Co-Mutations, PD-L1 Expression, and Survival Outcomes in Non-Small Cell Lung Cancer.

Nesrin Gürçay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.